Context: Point-of-care testing (POCT) for blood gas and chemistries is widely adopted in the emergency department (ED) for fast turnaround and critical medical decisions.
INTRODUCTION
In the emergency room, demands for near-instant biochemical test results have provided impetus for the development of user-friendly, portable devices capable of measurements that are as accurate as that from the central laboratory services. Point-ofcare testing (POCT) reduces the patient's length of stay in the emergency department (ED) 1,2 by reducing the turnaround time of laboratory tests, which translates to faster clinical decision-making 3 and data-driven disposition of the patient. While POCT has the potential to improve patient care and outcome, being fast with test results may not necessarily be beneficial if workplace conditions and processes do not have strategies to prevent medical errors. Confounding factors to achieving good results have surfaced in actual practice. Errors in test results could result from lapses in operator skills level, storage of reagents and maintenance of analysers 4 .
Most evaluations of POCT test devices have been reported by laboratory technologists. Few have compared real situation analysis of these devices.
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We have assessed the performance of point-ofcare tests with the Abbott i-STAT handheld analyser in the hands of ED physicians and laboratory technologists, and compare them with the hospital's central clinical biochemistry laboratory results. Operator skills level impact on the i-STAT's performance was also examined by comparing 2 operators from ED and the central laboratory.
MATERIAL AND METHODS
The Abbott i-STAT (Abbott Point of Care, East Windsor, NJ, USA) is a handheld unit that utilises single-use disposable cartridges. Each cartridge has a biosensor that consists of micro-fabricated thin film electrodes and reagents. Electrochemical signals specific for each analyte are measured via amperometric, potentiometric or conductiometric circuits. Patient and operator identification can be entered into the analyser and results, available in 2 minutes, are displayed on a screen and printed by transmission of infra-red signals to a printer.
This study was carried out in the ED and central clinical biochemistry laboratory of a tertiary general hospital. ED physicians and laboratory technologists underwent training, by vendor personnel, that consisted of audiovisual presentation and handson experience.
The study had ethical approval from the hospital's Institutional Review Board.
The i-STAT units, cartridges, reagents and aqueous QC material were provided by the local supplier for Abbott Point of Care. Test cartridges were stored in conditions stipulated by the manufacturer. Electronically simulated quality control (QC) was performed daily. For each new lot of cartridges, quality control using aqueous QC material at 2 concentration levels was also performed.
Study Population and Samples
For the purpose of platform and user skills comparison, blood specimens from patients were tested. Patients attending the ED over a 3-month period were recruited by ED physicians who attended to them. Subjects were included if they required routine investigations for blood gases, electrolytes, glucose, urea and creatinine. All suitable subjects were guided through a Patient Information Sheet with written informed consent signed in the presence of the physician and a witness. Informed consent was primary for permission to collect additional blood from the patient during the primary phlebotomy attempt.
Exclusion criteria included those who did not or could not give written consent, or whose guardian did not consent to the patient's participation in the study. Inclusion or exclusion from the study had no impact on the recruited patients as laboratory results from the central laboratory were used for patient management.
Study Protocol
Whole blood from the study population (n=60) was collected in lithium-heparin syringes and analysed on the i-STAT units (all test parameters) and the ABL 520 analyser (blood gas parameters; Radiometer A/S, Bronshoj, Denmark). Blood collected in serum separator plain tubes was used for analysis on the Beckman-Coulter LX20PRO (biochemical parameters; Beckman-Coulter Inc, Fullerton, CA, USA).
The analytes evaluated on the i-STAT were sodium, potassium, chloride, glucose, urea, creatinine, pH, pO 2 and pCO 2 . Sodium, potassium, chloride, glucose and urea analyses were performed on 6+ cartridges while creatinine and blood gas analyses were performed on creatinine and G3+ cartridges respectively.
Platform and User Skills Comparison
Two i-STAT units were used. The first unit (herein named AEiStat) was placed in the ED and operated by ED physicians at the patient's bedside. The second i-STAT unit (herein named B6iStat) was placed in the central clinical biochemistry laboratory and operated by laboratory technologists. run CVs calculated for all the test parameters (blood gas and biochemical parameters) performed side by side by both operators.
Analytical Performance of i-STAT
Analytical imprecision at 2 concentration levels for each analyte was evaluated by another laboratory technologist using aqueous QC material provided by the manufacturer. Withinrun imprecision was assessed by analysing the QC material consecutively 21 times within a single run and between-run imprecision was assessed by analysing the QC material once on 21 consecutive days. The coefficient of variation (CV), a measure of imprecision was computed from the mean and standard deviation of the test results.
The measuring ranges for the various analytes were also validated with stepwise analyte concentrations prepared by serial dilution of the high concentration quality control materials with saline.
Data Analysis
All statistical analyses were performed using Excel Analyse-It Version 2.03 (Analyse It Software Ltd, Leeds, United Kingdom). Imprecision for each analyte as given by the coefficient of variation (CV) was calculated from the standard deviation divided by the results mean. Overall within-run imprecision (CV) was computed from the square root of the sum of squares of CVs of all the parameters tested. The Deming regression and Spearman coefficient of correlation (rs 2 ) were applied to platform comparison test results by medical staff (using the AEiStat) and laboratory technologists (using B6iStat). Agreement statistics (mean bias and 95% agreement limits) by the Altman-Bland plot were computed to determine degree of agreement with laboratory results.
RESULTS

Platform and User Skills Comparison
There was good correlation between the i-STAT (B6iStat) that was placed in the central laboratory and the laboratory analysers. Correlation was poorer for the i-STAT (AEiStat) in the ED especially for sodium, chloride, potassium and pO 2 (slopes -0.45 to 1.23; rs 2 -0.49 to 0.71) ( Table 1 , overleaf ). Agreement statistics showed that overall, results obtained by the laboratory technologist (on the B6iStat) showed lower bias than ED physician. Of particular note is that of pO 2 where bias was averaging -18.3 mmHg with a wide range from -84.6 to 48.1 mmHg.
In terms of test repeatability, performance results for the ED physician were not comparable to that of the laboratory technologist. Overall within-run imprecision for biochemical parameters -sodium, chloride, potassium, glucose, urea and creatinine -for the ED physician was 5.4% CV versus 3.7% CV for the laboratory technologist. This performance difference was further widened when blood gases results were included in the data analysis -performance of the ED physician deteriorated a further 3.38-fold (18.3% CV) compared to the laboratory technologist with a 1.89-fold increase (7.0% CV) in imprecision.
Analytical Performance of i-STAT
Good repeatability (within-run) and reproducibility (between-run) was observed for most analytes with the exception of a within-run CV of 9.5% at a mean low creatinine concentration of 67 μmol/L (Table 2, overleaf ). Linearity studies (data not shown) verified the dynamic ranges for all analytes claimed by the manufacturer.
DISCUSSION
The i-STAT analyser is portable, simple to maintain and operate. Its small size, light weight and portability eliminate the need for space required for larger analysers in the ED. Additionally, just a few drops of blood is required for analysis compared to a minimum 2 millilitres (for blood gas and biochemical tests) in the central laboratory. However, the present study highlights differences in performances of point-of-care testing by medical staff and laboratory technologists. Interoperator variability in the ED would appear to be much more than in the central laboratory. Despite the same training given to all users, i-STAT results obtained by laboratory technologists correlating closer to laboratory measurements would suggest better testing skills.
The poorer comparability between the i-STAT unit operated by ED physicians with the central laboratory analysers and the wider individual performance variation of the ED physician indicated that actual operation and use of the POCT analyser at near-patient setting by non-laboratory personnel may not adequately approach the skill level of laboratory technologists who are dedicated to quality testing.
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Analytical performance of the i-STAT evaluated by a "skilled" laboratory technologist supports the instrument capability to deliver accurate test results. It has little impact however, on accuracy of results at bedside testing by non-laboratory personnel.
POCT is intended to reduce time to test results, offering sooner clinical decision making and reduction in length of stay of the patient in the ED [1] [2] [3] 5 . In our study, instead of the usual wait of at least an half an hour up to a couple of hours for laboratory test results, use of the i-STAT was able to produce results within 2 minutes. Patients could be appropriately discharged or moved quickly into the hospital system and reduce overcrowding in the ED as well as free the staff to receive the next patient 6 .
Other advantages also included the extensive menu of tests 7 and eliminating the need to deliver blood samples to the central laboratory. Outcome improvement may include earlier intervention advantages, such as treatment of hyperkalaemia or blood-gas disorders. However, being portable, the analyser may be moved to the patient's bedside and be easily "lost" to the next user. Also, infection control may be an issue as the analyser is brought from one patient's bedside to another.
It has been emphasised that the entire phases of POC testing from pre-analytic through analytic and post-analytic, have latent conditions that can lead to gross medical errors 4, 8, 9 . Continuous awareness of these attributes in laboratory testing may be lacking in the clinical department. The small blood volume requirements of POCT can also prevent assessment of sample quality and integrity, something that the central laboratory is always on the lookout for. Hence, despite the myriad of advantages, it must be emphasised that POCT benefits will only be realised with rigorous training, competency testing and quality control measures instituted. It is important to recognise that POCT results are highly operator dependant. Preanalytics such as storage conditions for reagents, individual staff competency and knowledge of confounding factors on test result interpretation are equally important.
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